RNAC
Cartesian Therapeutics Inc.
$8.17
+$0.06(+0.74%)
35
Overall
40
Value
30
Tech
--
Quality
Market Cap
$216.34M
Volume
33.56K
52W Range
$7.88 - $26.50
Target Price
$36.43
Key Metrics Overview
| Market Cap | $216.34M | P/E Ratio | N/A |
| 52W High | $26.50 | 52W Low | $7.88 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -173.1% | 52W Position | 1.6% |
| Overall Score | 35 | Value Score | 40 |
| Quality Score | -- | Technical Score | 30 |
Growth Analysis
| EPS Current Est | $-2.11 | EPS Next Est | $-3.49 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.17 | +0.7% | 33.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW